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Abstract
Aims: The aim of this study was to determine the treatment outcome 
of spider naevi using pulse dye laser (PDL) therapy.
Patients and Methods: This was a retrospective study reviewing 
the results of PDL on spider naevi in 49 consecutive patients under-
going PDL for spider naevi, between 15 October 2003 and 19 August 
2008. A questionnaire was used to investigate patient satisfaction and 
recurrence.
Results: There was improvement seen in all patients with complete 
resolution in 31 patients (76%) and 67 lesions (82%).
There was a high level of satisfaction with the treatment with 30 
patients (78%) being very satisfied and six (15%) satisfied with the re-
sult. Hypopigmentation occurred in one patient. Two patients (4.9%) 
with a total of four lesions developed recurrence in two lesions only. 
Conclusions: PDL is an effective and safe treatment of spider naevi.
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Introduction
Spider naevi are benign cutaneous vascular le-
sions that involve a group of pulsatile and dilated 
arterioles. The collection of these vessels has a cen-
tre that blanches when pressure is applied to its 
centre.1 These lesions are common and occur in 15 
percent of children and adults.2 Although they are 
harmless, they may cause significant cosmetic pro-
blems. They commonly appear on exposed areas 
such as the face, upper trunk and upper limbs2-5 
and less commonly on the lower limbs and lower 
trunk.4
Various treatment modalities such as electrocau-
tery, sclerotherapy and laser therapy have been used 
for spider naevi. Electrocautery may be associated 
with excessive bleeding and scarring. Older lasers, 
including the argon laser, have been associated with 
an unacceptably high incidence of scarring and pig-
mentary changes.2
Previous reports2,5 show effectiveness of PDL 
on spider naevi however, follow up has been limi-
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ted. The aim of this study was to determine the 
treatment outcome of spider naevi using pulse PDL.
Patients and Methods
This was a retrospective study which reviewed 
consecutive patients undergoing PDL for spider nae-
vi at our laser service between 15 October 2003 and 
19 August 2008. 
The patients were culled from our prospective 
laser database and information was supplemented 
by review of the medical records. The information 
collected was of the age, sex, number and location 
of the lesions, the number of treatment sessions for 
each patient.
PDL treatment was carried out as an outpatient 
procedure using the Candela V Beam with a dynamic 
cooling device (set at 30/30) using fluences of 10.5 
joules/cm2 and 1.5msec using a 7mm hand piece. 
An additional pulse of 15 joules/cm2 at 6msec using 
5mm hand piece to lesions with a raised centre. The 
number of pulses depended on the size of lesions 
overlapped by 1mm.
A questionnaire was dispatched to adult patients 
and the parents of children on previous treatments, 
outcomes, recurrence, side effects and satisfaction. 
Those who had not responded within four weeks 
were telephoned and the questionnaire was com-
pleted.
Data were entered into a Microsoft Excel spread-
sheet and analysed.
Results
49 patients aged 7 months to 63 years (mean, 21 
years) with 76 (mean, 1.6; range 1-5) spider naevi 
were treated with PDL. 39 (80%) patients were fe-
males. The lesions were located on the face (n=65) 
and upper limbs (n=11). Eight (20%) patients had 
previous unsuccessful treatment to PDL with liquid 
nitrogen (n=2) and, electrocautery (n=5) and topical 
cream (n=1).
41 (84%) patients completed and returned the 
questionnaire. The average follow-up period was 46 
(range, 15-66) months. 28 patients were contacted 
by phone and completed the questionnaires. Eight 
patients were not contactable.
Complete resolution of the lesions occurred in 
31 patients (76%) with 67 lesions (82%). Out of 
these, 25 patients (81%) with 45 lesions (67%) re-
solved completely after only one treatment. Three 
patients with seven lesions (10%) required two 
treatments. One with one lesion (1.5%) underwent 
three treatments. One with one lesion (1.5%) had 
four and one with one lesion (1.5%) had eight. 
10 patients (24%) had partial resolution. Two pa-
tients moved cities during treatment and had not 
completed their treatment course. 
Six out of the eight patients who had previous 
treatment had complete resolution whilst the two 
who had electrocautery before had partial resolu-
tion.
Two patients (4.9%) with a total of four lesions 
developed recurrence in two lesions only. 
Five patients developed temporary hyperpigmen-
tation and one patient experienced hypopigmenta-
tion.
30 of the 41 responders (73%) were very satisfied 
and six (15%) were satisfied with the result. One 
patient of the 41 responders (2.4%) who was very 
dissatisfied did not complete the treatment as she 
had relocated cities following two treatments. She 
recommended the treatment for others and stated 
she would like to come back for further treatment. 
Another patient who developed a partial recurrence 
one year following treatment was dissatisfied with 
the outcome. 
38 patients out of 41 (93%) would recommend 
the treatment to others. Two patients (4.9%) said 
they did not know and one (2.4%) said no.
INTERNATIONAL ARCHIVES OF MEDICINE
Section: Dermatology
ISSN: 1755-7682 
2015
Vol. 8 No. 177
doi: 10.3823/1776
© Under License of Creative Commons Attribution 3.0 License 3
Discussion
This study shows an  overall satisfactory response 
to PDL with complete eradication of spider naevi in 
76% of cases with 55 lesions (82%) with a recurren-
ce in 6.5% of patients and 3.6% of lesions with an 
average of 3.5 years follow up. Most patients would 
recommend PDL to others. Side effects were usually 
mild and temporary and this reflected the selectivity 
of PDL in targeting vascular structures and preven-
ting damage to surrounding structures.2 
Conclusion
To our knowledge this is the largest study on 
spider naevi treated with PDL in terms of number 
of patients and also the longest follow-up period.
PDL is effective and safe for the treatment of 
spider naevi. 
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